Genetics can spike Indians' cholesterol, but relief may be at hand

Novartis drug Pelacarsen that targets Lp(a) cholesterol is in global phase 3 trials. Last year, the company launched cholesterol-lowering drug Inclisiran in India under brand name Sybrava. Eli Lilly is working on Lepodisiran, while Amgen is also doing trials for Olpasiran.

Industry